@article{CCO1768,
author = {Bruce D. Minsky},
title = {Future of therapy for rectal cancer},
journal = {Chinese Clinical Oncology},
volume = {2},
number = {2},
year = {2013},
keywords = {},
abstract = {Since 2004, the standard of care for patients with cT3 and/or N+ rectal cancer has been preoperative chemoradiation followed by surgery and postoperative adjuvant chemotherapy. A number of advances have occurred and are defining the future of rectal cancer therapy. Among these are short course radiation, the impact of postoperative adjuvant chemotherapy, selective radiation and selective surgery, and new chemoradiation regimens with novel agents. This review will examine these developments and assess their impact on the future therapy of rectal cancer.},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/1768}
}